HCA Healthcare Rises 1.75% on $400M Volume, Lands at 254th in U.S. Liquidity Rankings

HCA Healthcare (HCA) rose 1.75% on Sept. 24, 2025, with a trading volume of $400 million, ranking it 254th in terms of liquidity among U.S. equities. The stock's performance reflected investor focus on operational updates and sector positioning, despite broader market volatility.

Recent developments highlighted HCA's strategic initiatives in expanding its outpatient services and optimizing capital allocation. Analysts noted that the company's ability to maintain margins amid rising healthcare costs and regulatory shifts contributed to the rally. A pending partnership with a regional diagnostics provider, though not disclosed in detail, was cited as a potential catalyst for long-term growth.

Market participants also weighed HCA's exposure to Medicaid reimbursement reforms, which remain under congressional review. While uncertainty persists, the stock's resilience suggested confidence in management's ability to navigate policy risks. Short-term momentum was further supported by reduced short-interest levels compared to peers, indicating a shift in sentiment among institutional investors.

To run this back-test rigorously I need to pin down a few implementation details: 1. Universe of stocks • U.S. listed common stocks (NYSE + NASDAQ) – my default assumption • Another universe? (e.g., all A-shares, STOXX 600, etc.) 2. Price points for entry and exit • Buy at next-day open, sell at the same day’s close (typical for daily re-balance) • Buy at today’s close, sell at tomorrow’s close Please indicate your preference. 3. Transaction-cost assumptions (commission, slippage) – ignore by default unless you’d like them included. 4. Any corporate-action filters? (e.g., exclude OTC, ADRs, low-price stocks) If the above defaults are acceptable (U.S. stocks, open-to-close returns, zero costs), just let me know and I’ll proceed. Otherwise please specify any changes.